Mordor Intelligence has published a new report on critical ischemia treatment market offering a comprehensive analysis of trends, growth drivers, and future projections.

The growth of the acute ischemic stroke market is expected to be driven primarily by increased awareness of symptoms, advances in acute stroke care, and a robust pipeline of potential candidates such ...

Company to Highlight Imaging Biomarkers for Cytoprotection and Post Hoc Analysis from Phase 2 RESCUE Clinical Trial; RNS60 Led to Shorter Hospital Stays in Acute Ischemic Stroke Subjects Enrolled with ...

Exercise-induced ST-segment depression ≥ 1.0 mm ≥ 1 episode of reversible ST-segment depression ≥ 1.0 mm during 48-hour ambulatory electrocardiographic (ECG) monitoring of routine activities. Patients ...

Treatment is determined by the type of stroke suffered (i.e., ischemic or hemorrhagic) rather than the anatomic location. Symptoms referable to the anterior circulation — specifically, anterior and ...

TNKase is administered as a single intravenous bolus over 5 seconds. The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in ...

Advances in cancer treatment mean that more people than ever are surviving the disease. However, some of the most effective ...

Ischemic colitis and mesenteric ischemia are both types of bowel ischemia. Ischemic colitis refers to reduced blood flow to the large intestine, while mesenteric ischemia happens due to reduced blood ...

Mesenteric ischemia, or small bowel ischemia, involves a blockage of blood flow to the small intestine. Symptoms include pain and bloating. It often results from blood clots or atherosclerosis.

Alternate treatment options Although thrombolytics can produce dramatic responses for those patients who are eligible to receive treatment, the actual number of people who qualify for this therapy is ...